We conducted this retrospective cohort study to (1) investigate the clinical characteristics, including the chronology of clinical symptoms of patients positive for anti-SAE1 autoantibody using a commercially available LIA, and (2) elucidate the clinical relevance of ILD with SAE1 autoantibody positivity in Taiwanese patients. This evidence concerns the gene SAE1 and interstitial lung disease.